Current Treatment Options in Neurology

Journal Title
Current Treatment Options in Neurology

CURR TREAT OPTION NE

ISSN / eISSN
1092-8480 / 1534-3138
Aims and Scope
This journal aims to review the most important, recently published treatment option advances in the field of neurology. By presenting clear, insightful, balanced contributions by international experts, the journal intends to facilitate worldwide approaches to the treatment of neurologic conditions.

We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as epilepsy, headache, neurologic ophthalmology and otology, neuromuscular disorders, psychiatric manifestations of neurologic disease, and sleep disorders. Section Editors select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. We also provide commentaries from well-known neurologists, and an international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research.
Subject Area

CLINICAL NEUROLOGY

CiteScore
4.00 View Trend
CiteScore Ranking
Category Quartile Rank
Medicine - Neurology (clinical) Q2 #196/400
Web of Science Core Collection
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
Category (Journal Citation Reports 2024) Quartile
CLINICAL NEUROLOGY Q3
H-index
38
Country/Area of Publication
US
Publisher
Springer US
Publication Frequency
Bimonthly
Year Publication Started
1999
Annual Article Volume
32
Open Access
NO
Contact
CURRENT MEDICINE GROUP, 400 MARKET STREET, STE 700, PHILADELPHIA, USA, PA, 19106

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More